HomeInsightsResults

Astec Lifesciences Ltd Quarterly Result

Astec Lifesciences Ltd Quarterly Result

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

0.3 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Astec Lifesciences Ltd

NSE: ASTEC

Net Profit

₹ -38.55

Last updated on: Nov 23, 2024

Key Highlights

  • The revenue of Astec Lifesciences Ltd for the Sep '24 is ₹ 100.54 crore as compare to the Jun '24 revenue of ₹ 70.3 crore. This represent the growth of 43.01564%.
  • The ebitda of Astec Lifesciences Ltd for the Sep '24 is ₹ -17.74 crore as compare to the Jun '24 ebitda of ₹ -45.33 crore. This represent the decline of -60.864773%.
  • The net profit of Astec Lifesciences Ltd for the Sep '24 is ₹ -38.55 crore as compare to the Jun '24 net profit of ₹ -39.72 crore. This represent the decline of -2.9456244%.

Results Analysis

Market Price of Astec Lifesciences Ltd

1M

1Y

3Y

5Y

Monitoring Astec Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20241060.65
21 Nov 20241052.15
19 Nov 20241062.85
18 Nov 20241053.35
14 Nov 20241061.05
13 Nov 20241059.85
12 Nov 20241060.2
11 Nov 20241075.25
08 Nov 20241068.55
07 Nov 20241081.4

Historical Revenue of Astec Lifesciences Ltd

No data available

* All values are in crore

Historical EBITDA of Astec Lifesciences Ltd

No data available

* All values are in crore

Historical Net Profit of Astec Lifesciences Ltd

No data available

* All values are in crore

Astec Lifesciences Ltd News Hub

News

Astec Lifesciences to hold board meeting

Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 25 Octo...

Read more

09 Oct 202417:29

News

Astec LifeSciences director resigns

Astec LifeSciences announced that Dr. Brahma Nand Vyas has tendered his resignation as an ...

Read more

04 Oct 202419:08

News

Astec Lifesciences announces resignation of Director cum CEO

Astec Lifesciences announced that Anurag Roy has tendered his resignation as the 'Whole Ti...

Read more

23 Sep 202418:06

News

Astec Lifesciences appoints director

Astec Lifesciences has appointed Dr. Ganapati Dadasaheb Yadav as a 'Non-Executive & Indepe...

Read more

17 Sep 202419:28

News

Astec Lifesciences to discuss results

Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 29 July...

Read more

18 Jul 202416:43

News

Astec Lifesciences to conduct AGM

Astec Lifesciences announced that the Annual General Meeting(AGM) of the company will be h...

Read more

03 May 202417:05

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQ's For Astec Lifesciences Ltd Quarterly Result

What is the EPS of Astec Lifesciences Ltd stock?

The Earnings Per Share (EPS) of Astec Lifesciences Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Astec Lifesciences Ltd EPS calculated?

The EPS of Astec Lifesciences Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Astec Lifesciences Ltd report its EPS?

Astec Lifesciences Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Astec Lifesciences Ltd EPS?

Factors that influence the EPS of Astec Lifesciences Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Astec Lifesciences Ltd EPS growth indicate future performance?

Yes, consistent growth in Astec Lifesciences Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*